BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 95656)

  • 1. [Heredopathia atactica polyneuritiformis. Hexadecanoic acid storage disease (Refsum's disease). Definition, treatment and pathogenesis. A short review].
    Refsum S
    Psychiatr Neurol Med Psychol Beih; 1977; 22-23():11-8. PubMed ID: 95656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heredopathia atactica polyneurotiformis: therapeutic and pathogenetic aspects.
    Refsum S
    Riv Patol Nerv Ment; 1976 Jun; 97(3):115-26. PubMed ID: 74082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heredopathia atactica polyneuritiformis phytanic-acid storage disease, Refsum's disease:" a biochemically well-defined disease with a specific dietary treatment.
    Refsum S
    Arch Neurol; 1981 Oct; 38(10):605-6. PubMed ID: 6170281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Refsum's syndrome (author's transl)].
    Thümler R; Atzpodien W; Kremer GJ; Haferkamp G
    Dtsch Med Wochenschr; 1977 Oct; 102(41):1454-7. PubMed ID: 71982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and biochemical follow up of Refsum's disease (author's transl)].
    Barolin GS; Hodkewitsch E; Höfinger E; Scholz H; Bernheimer H; Molzer B
    Fortschr Neurol Psychiatr Grenzgeb; 1979 Feb; 47(2):53-66. PubMed ID: 84779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phytanic-acid storage disease: Refsum's syndrome. Heredopathia atactica polyneuritiformis].
    Atzpodien W; Thümler R; Kremer GJ
    Dtsch Med Wochenschr; 1977 Oct; 102(41):1480-4. PubMed ID: 71983
    [No Abstract]   [Full Text] [Related]  

  • 7. [Refsum syndrome, heredopathia atactica polyneuritiformis in the view of the otolaryngologist (author's transl)].
    Feldmann H
    Laryngol Rhinol Otol (Stuttg); 1981 May; 60(5):235-40. PubMed ID: 6164893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heredopathia atactica polyneuritiformis (Refsum's Disease): a second trial of dietary therapy in two patients.
    Kark RA; Engel WK; Blass JP; Steinberg D; Walsh GO
    Birth Defects Orig Artic Ser; 1971 Feb; 7(1):53-5. PubMed ID: 4141911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of plasma phytanic acid levels in adults.
    Britton TC; Gibberd FB; Clemens ME; Billimoria JD; Sidey MC
    J Neurol Neurosurg Psychiatry; 1989 Jul; 52(7):891-4. PubMed ID: 2475586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heredopathia atactica polyneuritiformis (phytanic acid storage disease). A new case with special reference to dietary treatment.
    Sahgal V; Olsen WO
    Arch Intern Med; 1975 Apr; 135(4):585-7. PubMed ID: 49180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heredopathia atactica polyneuritiformis: phytanic acid storage disease (Refsum's syndrome). Effect of diet therapy on retinal and cochlear changes].
    Refsum S
    Neurol Neurochir Pol; 1984; 18(1):1-4. PubMed ID: 6203044
    [No Abstract]   [Full Text] [Related]  

  • 12. [Refsum's disease: evolution 35 years after diagnosis].
    Marcaud V; Defontaines B; Jung P; Degos CF
    Rev Neurol (Paris); 2002 Feb; 158(2):225-9. PubMed ID: 11965181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange.
    Gibberd FB; Billimoria JD; Page NG; Retsas S
    Lancet; 1979 Mar; 1(8116):575-8. PubMed ID: 85164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heredopathia atactica polyneuritiformis: Refsum's disease.
    Gibberd FB; Billimoria JD; Goldman JM; Clemens ME; Evans R; Whitelaw MN; Retsas S; Sherratt RM
    Acta Neurol Scand; 1985 Jul; 72(1):1-17. PubMed ID: 2413704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heredopathia atactica polyneuritiformis (Refsum's disease): 1. Clinical features and dietary management.
    Masters-Thomas A; Bailes J; Billimoria JD; Clemens ME; Gibberd FB; Page NG
    J Hum Nutr; 1980 Aug; 34(4):245-50. PubMed ID: 6157716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Refsum's disease. Epidemiologic, clinical and biological correlation. 6 cases].
    Petit H; Leys D; Skjeldal OH; Caron JC; Lambert P; Lehembre P; Hache JC
    Rev Neurol (Paris); 1986; 142(5):500-8. PubMed ID: 2431446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heredopathia atactica polyneuritiformis (Refsum's disease): 2. Estimation of phytanic acid in foods.
    Masters-Thomas A; Bailes J; Billimoria JD; Clemens ME; Gibberd FB; Page NG
    J Hum Nutr; 1980 Aug; 34(4):251-4. PubMed ID: 6157717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid composition of tissues in Refsum's disease (herodopathia atactica polyneuritiformis). Estimation of total phytanic acid accumulation.
    Malmendier CL; Jonniaux G; Voet W; Van Den Bergen CJ
    Biomedicine; 1974 Nov; 20(6):398-407. PubMed ID: 4141904
    [No Abstract]   [Full Text] [Related]  

  • 19. Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation.
    Wierzbicki AS; Lloyd MD; Schofield CJ; Feher MD; Gibberd FB
    J Neurochem; 2002 Mar; 80(5):727-35. PubMed ID: 11948235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Di-, mono- and nonphytanyl triglycerides in the serum: a sensitive parameter of the phytanic acid accumulation in Refsum's disease.
    Molzer B; Bernheimer H; Barolin GS; Höfinger E; Lenz H
    Clin Chim Acta; 1979 Jan; 91(2):133-40. PubMed ID: 83207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.